🇬🇧 United Kingdom Country × Condition
melanoma Clinical Trials in United Kingdom
Active clinical trials for melanoma with research sites in United Kingdom. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇬🇧 United Kingdom
Active Trials in United Kingdom (2)
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Enrollment
30 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → NCT05768178 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Enrollment
30 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → Frequently Asked Questions
How many melanoma clinical trials are active in United Kingdom?
There are currently 2 active clinical trials for melanoma with sites in United Kingdom, of which 2 are actively recruiting patients.
How can I join a melanoma clinical trial in United Kingdom?
To join a melanoma clinical trial in United Kingdom, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United Kingdom directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are melanoma trials in United Kingdom?
Active melanoma trials in United Kingdom span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.